drugset / Trial / NCT00191529

Growth Hormone Treatment in Short Children Born Small for Gestational Age

NCT00191529

Phase 3 Completed 200 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of 2 different doses of human growth hormone treatment on change in height after 1 and 2 years of treatment.

Timeline

Start
2002-12
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.035 mg/kg
Subject Somatropin Protein / enzyme biologic 0.067 mg/kg